U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822504) titled 'Prevalence of Sarcopenic Obesity in COPD' on June 07, 2024.
Brief Summary: The goal of this observational study is to the purpose is to apply of ESPEN/EASO criteria for the diagnosis of sarcopenic obesity and calculation of OS prevalence in a sample of COPD patients.
In addition, this study want to evaluate the impact of sarcopenic obesity on the respiratory function of COPD patients and the degree of severity of respiratory disease, assessed by spirometric examination; diaphragm thickness and excursion, by ultrasonographic study; performance, assessed by six-minute walk test (6-MWT); quality of life and degree of dyspnea (mMRC, Ba...